Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

UCB Biosciences Inc.
Sponsor

UCB Biosciences Inc.

United States 4000 Paramount Parkway Suite 200, 27560-8484, United States

About the sponsor

Clinical research activity includes thymidine kinase 2 deficiency, with interest in therapies for inherited conditions that affect muscle function and cellular energy metabolism.

  • Thymidine kinase 2 deficiency
  • Inherited myopathy
  • Mitochondrial disease

Work in this area centers on treatment options for patients with persistent neuromuscular impairment and related rare disease manifestations.

About Specializations

UCB Biosciences Inc. runs clinical trials in conditions such as Rett syndrome, Mitochondrial DNA depletion, Severe myoclonic epilepsy of infancy, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

3 clinical trials

Rett syndrome

Recruiting
Registered drug
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years
  • Substances:Fenfluramine Hydrochloride
  • Sponsor:UCB Biosciences Inc.

Mitochondrial DNA depletion

Not recruiting
InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Doxecitine
  • Sponsor:UCB Biosciences Inc.

Severe myoclonic epilepsy of infancy

Not recruiting
Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Fenfluramine Hydrochloride
  • Sponsor:UCB Biosciences Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.